Teisuke Takahashi

801 total citations
35 papers, 658 citations indexed

About

Teisuke Takahashi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Teisuke Takahashi has authored 35 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Teisuke Takahashi's work include Diabetes Treatment and Management (7 papers), Nitric Oxide and Endothelin Effects (5 papers) and Parathyroid Disorders and Treatments (3 papers). Teisuke Takahashi is often cited by papers focused on Diabetes Treatment and Management (7 papers), Nitric Oxide and Endothelin Effects (5 papers) and Parathyroid Disorders and Treatments (3 papers). Teisuke Takahashi collaborates with scholars based in Japan, United States and Germany. Teisuke Takahashi's co-authors include Noriyuki Miyata, Richard J. Roman, Naoki Kojima, Jan M. Williams, Toshio Matsuda, Akemichi Baba, Sota Kato, Saeko Uchida, Taizo Suzuki and Yu Tanaka and has published in prestigious journals such as Endocrinology, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

Teisuke Takahashi

34 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Teisuke Takahashi Japan	12	283	269	157	150	87	35	658
Masaya Fukuda Japan	16	229 0.8×	130 0.5×	238 1.5×	85 0.6×	40 0.5×	21	802
Masanori Fukazawa United States	14	373 1.3×	500 1.9×	66 0.4×	294 2.0×	52 0.6×	33	857
Gerd Luippold Germany	19	396 1.4×	193 0.7×	151 1.0×	140 0.9×	105 1.2×	44	883
Yi‐Fei Dong Japan	20	320 1.1×	274 1.0×	494 3.1×	135 0.9×	62 0.7×	27	1.2k
Nobuhiro Miyamura Japan	18	369 1.3×	414 1.5×	126 0.8×	284 1.9×	36 0.4×	37	1.1k
Pin‐Lan Li United States	15	364 1.3×	219 0.8×	142 0.9×	101 0.7×	80 0.9×	30	1.2k
Xiaoping Ruan United States	15	302 1.1×	282 1.0×	252 1.6×	133 0.9×	56 0.6×	26	715
Shin Aoki Japan	18	396 1.4×	726 2.7×	96 0.6×	209 1.4×	54 0.6×	46	1.3k
Jürgen Fingerle Switzerland	18	238 0.8×	58 0.2×	135 0.9×	108 0.7×	52 0.6×	26	724
Hisato Nako Japan	13	167 0.6×	170 0.6×	275 1.8×	78 0.5×	40 0.5×	16	606

Countries citing papers authored by Teisuke Takahashi

Since Specialization

Citations

This map shows the geographic impact of Teisuke Takahashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teisuke Takahashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teisuke Takahashi more than expected).

Fields of papers citing papers by Teisuke Takahashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teisuke Takahashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teisuke Takahashi. The network helps show where Teisuke Takahashi may publish in the future.

Co-authorship network of co-authors of Teisuke Takahashi

This figure shows the co-authorship network connecting the top 25 collaborators of Teisuke Takahashi. A scholar is included among the top collaborators of Teisuke Takahashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teisuke Takahashi. Teisuke Takahashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hikichi, Hirohiko, Jun-ichi Karasawa, Kenichi Fukumoto, et al.. (2025). Preclinical pharmacological profiles of vornorexant, a novel potent dual orexin receptor antagonist. Journal of Pharmacology and Experimental Therapeutics. 392(7). 103624–103624. 2 indexed citations

Suzuki, Ryō, Daisuke Matsuda, Mayumi Endo, et al.. (2023). Structure-based lead optimization to improve potency and selectivity of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid series of heparanase-1 inhibitor. Bioorganic & Medicinal Chemistry. 93. 117460–117460. 4 indexed citations

Hirata, Takashi, et al.. (2023). Renoprotective Effect of TP0472993, a Novel and Selective 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, in Mouse Models of Renal Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 386(1). 56–69.

Suzuki, Ryō, et al.. (2023). Discovery of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent and selective heparanase-1 inhibitor utilizing an improved synthetic approach. Bioorganic & Medicinal Chemistry Letters. 97. 129543–129543. 2 indexed citations

Tanaka, Hiroki, Makoto Hamada, Yuji Ito, et al.. (2022). Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 Inhibition. Journal of Medicinal Chemistry. 65(21). 14599–14613. 5 indexed citations

Ohta, Hiroshi, et al.. (2022). Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo [b]thiophene derivatives as gut-selective NaPi2b inhibitors. Bioorganic & Medicinal Chemistry Letters. 59. 128572–128572. 5 indexed citations

Ohta, Hiroshi, et al.. (2022). Design, synthesis and biological evaluation of novel indole derivatives as gut-selective NaPi2b inhibitors. Bioorganic & Medicinal Chemistry. 66. 116783–116783. 3 indexed citations

Suzuki, Ryō, et al.. (2022). Lead identification of novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent heparanase-1 inhibitor. Bioorganic & Medicinal Chemistry Letters. 79. 129050–129050. 5 indexed citations

Kato, Sota, Teisuke Takahashi, Noriyuki Miyata, & Richard J. Roman. (2019). DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats. Journal of Pharmacology and Experimental Therapeutics. 372(2). 166–174. 14 indexed citations

10.

Takahashi, Teisuke & Koji Yamamoto. (2015). Pharmacological and clinical profile of a new SGLT2 inhibitor, luseogliflozin (Lusefi<sup>®</sup>). Folia Pharmacologica Japonica. 146(3). 150–158. 1 indexed citations

11.

Uchida, Saeko, et al.. (2015). In vitro characterization of luseogliflozin, a potent and competitive sodium glucose co-transporter 2 inhibitor: Inhibition kinetics and binding studies. Journal of Pharmacological Sciences. 128(1). 54–57. 14 indexed citations

12.

Nakai, Yasuhiro, Saeko Uchida, Teisuke Takahashi, et al.. (2014). A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans. Drug Metabolism and Disposition. 42(9). 1456–1465. 5 indexed citations

13.

Kojima, Naoki, Jan M. Williams, Teisuke Takahashi, Noriyuki Miyata, & Richard J. Roman. (2013). Effects of a New SGLT2 Inhibitor, Luseogliflozin, on Diabetic Nephropathy in T2DN Rats. Journal of Pharmacology and Experimental Therapeutics. 345(3). 464–472. 124 indexed citations

14.

Kojima, Naoki, Jan M. Williams, Teisuke Takahashi, Noriyuki Miyata, & Richard J. Roman. (2012). Abstract 221: Renoprotective Effects of SGLT2 Inhibitor, Luseogliflozin, on the Progression of Diabetic Nephropathy in T2DN Rats. Hypertension. 60(suppl_1). 1 indexed citations

15.

Ago, Yukio, et al.. (2011). SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson’s disease. Neuropharmacology. 61(8). 1441–1451. 24 indexed citations

16.

Takahashi, Teisuke, Kenzo Takahashi, Taizo Suzuki, et al.. (2004). Effects of SEA0400, a novel inhibitor of the Na+/Ca2+ exchanger, on myocardial stunning in anesthetized dogs. European Journal of Pharmacology. 505(1-3). 163–168. 14 indexed citations

17.

Takahashi, Teisuke, et al.. (1997). Protective effects of CD-832 on organ damage in stroke-prone spontaneously hypertensive rats. European Journal of Pharmacology. 331(2-3). 193–198. 3 indexed citations

18.

Takahashi, Teisuke, et al.. (1994). Effects of a New Calcium Antagonist, CD-832, on Coronary and Systemic Hemodynamics in Conscious Dogs. Journal of Cardiovascular Pharmacology. 24(1). 8–12. 5 indexed citations

19.

Takahashi, Teisuke, et al.. (1993). Effects of a new calcium antagonist, CD-832, on experimental coronary artery spasm in miniature pigs. Cardiovascular Drugs and Therapy. 7(2). 265–271. 8 indexed citations

20.

Takahashi, Teisuke, Hiroaki Hisa, & S. Satoh. (1991). Serotonin-induced renin release in the dog kidney. European Journal of Pharmacology. 193(3). 315–320. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact